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Summary: An optimized assay is described for the catalytic activity dctermination of serum ribonuclease,
using polycytidylic acid äs Substrate and measuring the released acid-solubte ultra-violet absorbing products.
Rccommended final reaction concentrations are 0.3 mmol/1 polycytidylic acid, 200 mmol/1 imidazole/HCl
buffer, pH 7.0, and 50 mmol/1 NaCl. Optimal concentrations for the precipitation procedure, guaranteeing
sufficient precipitation and minimal decomposition of unreacted Substrate, are 160 mmol/1 perchloric acid
and 4 mmol/1 lanthanum nitrate. Coefficients of Variation for the method (within series and between days)
ranged from 2.2 to 7.9%. No sex-related diflferences of catalytic activity were observed. In 63 blood donors
with normal values of serum creatinine, the upper limit of the reference intervals (99th percentile) was 33.7
kU/1.
Eine optimierte Mikromethode zur Bestimmung der katalytischen Aktivität der Ribonuclease im Serum
Zusammenfassung: Eine optimierte Methode zur Bestimmung der katalytischen Aktivität der Ribonuclease
im Serum unter Verwendung des Substrats Polycytidylsäure wird beschrieben. Als optimale Reaktionsbedin-
gungen wurden 0,3 mmol/1 Polycytidylsäure, 200 mmol/1 ImidazoI/HCl-Puffer (pH 7,0) und 50 mmol/1 NaCl
ermittelt. 160 mmol/1 Perchlorsäure und 4 mmol/1 Lanthannitrat sind die Konzentrationen des Stopp-
Reagenses; diese Konzentrationen verhindern eine unspezifische Freisetzung von UV-absorbierenden Produk-
ten während der Präzipitation des nicht umgesetzten Substrats. Die Variationskoeffizienten für die Methode
(serielle und zeitliche Präzision) lagen zwischen 2,2 und 7,9%. Das obere Referenzintervall (99 Perzentile)
betrug bei 63 Blutspendern 33,7 kU/1.
troducüon patterns, differ in Substrate specificity (14, 15),
Ribonuclease (ribonucleate 3'-pyrimidino-oligonucle- methods mostly developed for the former have been
otidohydrolase; EC 3.1.4.22) has been assumed to be transferred to the serum enzyme assay (4, 7, 16, 17).
a valuable indicator for various pathological condi- As a result of this insufficient standardization, the
tions(l — 12). Basedon its endonucleolytic action, its widely used Substrate, polycytidylic acid, has been
determination is usually performed spectrophotomet- recommended in Substrate concentrations ranging
rically by measuring the absorbance of the short from 0.54 to 1.92 mmol/1 (4, 17). Therefore, in the
chain oligonucleotides produced enzymatically. How- current study the influence of different analytical
ever, among the numerous methods used, none takes variables on the catalytic activity of serum ribo-
into account the general optimization principles for nuclease has been examined, and an optimized
catalytic activity measurements (13). Although pan- method using polycytidylic acid äs Substrate is de-
creatic and serum ribonuclease, due to their isoen- scribed.
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Materials and Methods
Reagents and Solutions
Polycytidylic acid, potassium salt was obtained from
Boehringer Mannheim GmbH, Mannheim (FRG); the buffers
tris(hydroxymethyl)-aminometnane and N-tris(hydroxy-
methyl)methyl-2-aminoethanesulphonic acid from Serva Fein-
biochemica, Heidelberg (FRG); KH2PO4, K2HPO4, perchloric
acid, lanthanum nitrate from E. Merck GmbH, Darmstadt
(FRG); imidazole from Fluka, Buchs (Switzerland), and sodium
Chloride from VEB Laborchemie, Apolda (GDR). The sol-
utions mentioned below were made in triple distilled water. We
adjusted the pH of substrate/buffer Solutions at 37 °C, using
calibration buffers (Forschungsinstitut Meinsberg, GDR) pro-
duced according to the U. S. National Bureau of Standards.
Diluent: 150 mmol/1 sodium Chloride solution. 87.7 g of sodium
Chloride are dissolved in water and diluted to l liter.
Substrate solution: 300 mmol/1 imidazole/HCl buffer, pH 7.0,
0.45 mmol/1 polycytidylic acid. Imidazole (2.044 g) is dissolved
in about 80 ml of water, adjusted to pH 7.0 with hydrochloric
acid, and diluted with water to 100 ml. Then 25 mg of polycyti-
dylic acid are dissolved in this buffer solution. The Substrate/
buffer solution is stable for at least 3 weeks at —20 °C.
Stop solution: 20,0 mmol/1 perchloric acid, 5 mmol/1 lanthanum
nitrate. La(NO3)3 · 6 H2O (541 mg) is dissolved in 200 ml of
water, 4.3 ml of perchloric acid (1.67 kg/l) are added and
diluted to 250 ml with water.
Samples
Serum samples obtained from healthy blood donors were stored
at —20 °C and analysed not later than 3 weeks after collection.
For the optimization of analytical variables, equal volumes of
30 sera were mixed and used s sample.
Ribonuclease assay
The determination of ribonuclease is· based on the principle
described by Heppel'.et al. (18), namely, that polycytidylic acid
is hydrolysed by this enzyme during a fixed time incubation.
After precipitation of undegraded Substrate by perchloric acid-
lanthanum nitrate solution, the absorbance increase of super-
natant due to the release of acid-soluble oligonucleotides is
measured at 278 nm. The ribonuclease activity is calculated
using the molar lineic absorbance of 1300 m2 χ mol"5 for
cytidirie 3'-monophosphate (19). Results are expressed s kU/1.
One unit is defrned s the amount of enzyme which produces
l μηιοί of acid-soluble nucleotides per min at 37 °C under the
given reaction conditions.
The determination procedure is described in table 1. All mea-
s rements were made on a DU-8 Spectrophotometer (Beckman
Instruments, Fullerton, USA). The incubations were perfornied
in ribonuclease-free microcentrifuge tubes (Kombinat Beh lter-
und Verpackungsglas, Leipzig, GDR). For the centrifugations,
a refrigerated centrifuge, Model K 23 (VEB Zentrifugenbau,
Leipzig, GDR) was used.
Statistical evaluation
For the Statistical analysis of the results the tatest accprding to
Student was used. The distribution f ribonuclease values in
blood donors was estimated by the x2-test at the HP-9835 A
(Hewlett Packard, Palo Alto, USA).
Tab. l. Protocol for determining the catalytic activity of ribonuclease in serum.
Preparation of samples
Serum (10 μΐ) is diluted with 10 ml of diluent and used within 3 hours.
Assay
Sample
(μΐ)
Sample blank
(μΐ)
Reagent blank l
d)
Reagent blank 2
d)
Substrate
Diluted sample
Diluent
Stop solution
Calculation
kU/1
50 0
Incubation for 10 min at 37 °C
50
25 25 0
0 50 25
Incubation of reaction mixture for 15 min at 37 °C
0
75
300 300 300 300
The mixture is placed in an icebath for 30 min and then centrifuged for 12 min at 4000 g. 250 μΐ
of supernatant are removed and the absorbance is measured at 278 nm in a cuvette of 10mm
light path within 15 min
i — A2 — A3 + A4) χ Final volume (ml) χ ΙΟ3 χ F
ε χ Reaction time (min) χ Sample volume (ml) χ Light path (mm)
A! = absorbance of the sample assay
A2 =c absorbance of the sample blank
A3 = absorbance of the reagent blank l
A4 = absorbance of the reagent blank 2
F = dilution factor for serum sample
ε = 1300 m2/mol (molar lineic absorbance)
If F and reaction time are 1001 and 15, respectively, the foliowing formula will result:
A A x 0.375x103x1001
1300 χ 15 χ 0.025 χ 10 ~ Δ
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Results
Analytical variables
Buffer and pH
The catalytic activity of ribonuclease was measured
in the buffer Solutions of tris(hydroxymethyl)amino-
methane, N-tris(hydroxymethyl)methyl-2-aminoeth-
anesulphonic acid, imidazole, and potassium phos-
phate in the ränge pH 5.5 to pH 8.0 (Fig. 1). The pH
Optimum is clearly aflected by the buffers used. The
highest catalytic activity was obtained in 200 mmol/1
imidazole/HCl buffer, pH 7.0 (fig. l and 2). In the
other buffers investigated, the catalytic activity de-
creased with increasing concentrations (not shown).
Several batches of imidazole from different producers
(Ferak, Berlin; E. Merck, Darmstadt; Fluka, Buchs)
were examined. Using these different imidazoles, si-
milar catalytic activities but greatly differing blank
values were observed. The lowest reagent blank value
(about 0.100 A) was obtained with imidazole supplied
by Fluka.
Polycytidylic acid
The effect of the polycytidylic acid concentration on
catalytic ribonuclease activity was examined between
0.03 and 1.8 mmol/1 in serum and urine samples from
healthy persons and serum samples from patients
with elevated serum creatinine (fig. 3). The catalytic
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Fig. 1. Dependence of the catalyiic aotivity of serum ribo-
nuclease on pH. The final buffer concentratipns were
50 mmol/1 of tris(hydroxymethyl/aminomethane/HCl
(D a), 50 mmol/1 of N^tris^ydroxy-
methyl)methyl-2-aminoethanesulphonic acid/NaOH
(x—= x), 50 mmol/1 of potassium phosphate
(o o), and 200 nunol/1 of imidazole/HCl
(· ·) containing 0.3 mmol/1 of polycytidylic acid
and 50 mmol/1 NaCl. Each point is the mean of triplica-
tes.
activity increased in all the three samples investigated
up to about 0.3 mmol/1 of polycytidylic acid, whereas
a typical Substrate Inhibition effect was observed at
higher concentration of polycytidylic acid. However,
the extent of Inhibition differed among the samples.
This phenomenon of different Substrate Inhibition
may reflect the different isoenzyme composition of
the samples investigated. The polycytidylic acid con-
centration of 0.3 mmol/1 was selected for our pro-
posed method.
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Fig. 2. Dependence of the catalytic activity of serum ribo-
nuclease on imidazole concentration. Imidazole concen-
tration (pH 7.0) was varied äs indicated. Concentration
of polycytidylic acid and of NaCl äs in fig. 1. Each
point is the mean of triplicates.
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Fig. 3. Dependence of catalytic activity of serum ribonuclease
on the polycytidylic acid concentration. Final reaction
conditions: 200 mmol/1 imidazole/HCl buffer (pH 7.0),
50 mmol/1 NaCl, and polycytidylic acid äs indicated.
Three different samples were used:
o o, pool of serum samples with normal values
of serum creatinine (mixture of serum samples äs indi-
cated in "Materials and Methods");
B B, pool of serum samples with increased vaiues
of serum creatinine (mixture of 10 samples obtained
from kidney transplant reeipients);
o o, urine samples, obtained from healthy per-
sons.
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Influence ofcations
Numerous cations have been tested in the reaction
mixtures for ribonuclease determination (20—22),
but there is some disagreement over their effects on
the catalytic activity of ribonuclease (23). Comparing
the data in the literature, it is obvioüs that the effect
of cations on ribonuclease activity depends ön the
buffer and Substrate used (23). Therefore, their effects
under the above-stated reaction conditions had to be
investigated. The monovalent cations, sodium and
potassium, were studied at concentrations from 0 to
300 mmol/1, the divalent cations, magnesium and
calcium (all with chloride äs anions), from 0 to
8 mmol/1. The effect of NaCl is shown. iri' table 2.
A similar effect was demonstrated for KC1. With
increasing concentrations the inhibitory influence of
both cations is evident. MgCl2 and CaCl2 showed
about the same activation effect (20 — 30%) in the
concentrations studied. A combination of optimal
sodium and divalent cation concentrations, caused a
decrease in catalytic enzyme activity (tab. 2). Because
of these results, together with the results outlined in
the chapter of stability, 50 mmol/1 of NaCl were
included in the reaction mixture.
Tab. 2. Effect of NaCl and other cations on the analytic activity
of serum ribonuclease. Data are given äs fraction (arith-
metic mean ± SD; n = 3) of catalytic activity obtained
without cation added (22.4 kU/1). Ca2+ and Mg2+
when present, were at a concentration of 4 mmol/1.
Concentrations are final concentrations.
NaCl
(mmol/1)
0
50
(+ Ca2+)
(+ Mg2+)
(+ Ca2+ + Mg2+)
100
200
300
Catalytic activity fraction
1.000
1.230
0.565
0.395
0.649
0.589
0.064
0.009
+ 0.038
+ 0.027
+ 0.021
± 0.029
+ 0.034
+ 0.058
+ 0.002
+ 0.002
Stop solution and precipitätion procedure
The influence of perchloric acid äs well äs lanthanum
nitrate concentrations was examined (tab. 3). As final
concentrations of the precipitating reagent 160
mmol/1 perchloric acid and 4 mrngl/1 lanthanum ni-
trate were selected äs this combination leads to the
lowest absorbance in the superaatänt (tab. 3). Since
the blank valüe is not essentially influenced by the
perchloric acid concentration, it is assumed that a
stronger perchloric acid concentratioii döes not de-
stroy polycytidylic acid but decomposes depolyiner-
ized products resulting from the ribonuclease attack
upon polycytidylic acid. Therefore, the lowest absorb-
ance in the süpernatant (i. e. activity) indicates (tab.
3) that these conditions caüse sufficient precipitätion
and minimized decomposition of these products.
Linearity
The method shows a linear response for the catalytic
concentration of ribonuclease up to a net absorbance
of about 0.900 under the given assay conditions (flg.
4). Taking into account this absorbance limit, linear-
ity can be assumed over a reaction time of at least
30 min under the given conditions (fig. 5).
Stability
Owing to its high catalytic activity in serum, ribo-
nuclease has to be diluted for measurement. At first
the enzyme stability was tested after dilution. For
this purpose, dilutions of 10 serum samples both with
150 mmol/1 NaCl solution and with distilled water
were prepared and then stored at room temperature
(about 23 °C). Their activities were measured over a
period of 3 hours. In comparison with their starting
activities, the mean recoveries for the samples diluted
with the saline solution after that time were 101%
(Standard deviation 4.5%) and 117% (Standard de-
Tab. 3. Influence of precipitating reagents on the catalytic activity of measured ribonuclease. Catalytic activities are arithmetic
means ± SD of 4 determinations. Concentrations of reagents are final concentrations.
Activity
kU/1
kU/1
Precipitating reagent
A. Perchloric acid (mmol/1)
80 160
22.5 ±6.4 24.3 ±1.
B. 160 mmol/1 perchloric acid
0 1.6
23.2 ± 0.7 20.9 ± 1
320
.1 31.8 ±1.1
plus lanthanum nitrate
4 .
.2 18.8 + 1.4
640
36.7 ± 0.9
(mmol/1)
8
25.9 + 1.1
960
45.4 + 0.6
16
, y 31.5 + 1.1
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Fig. 4. Linearity of the assay. A serum sample was seriaUy
diluted with 150 mmol/1 of NaCl solution to prepare
different dilutions. Each point is the mean of triplicates.
At these temperatures, the samples did not lose their
catalytic activities over 5 days. However, it is recom-
mended that samples be stored at —20 °C when not
tested within 3 days.
In the complete reaction mixture, the enzyme was
stable for at least 30 min (see section on Linearity
and fig. 5).
Precision
Table 5 shows our precision data for the method.
Comparison with method according to Reddi
(7)
In comparison with the popul r and often cited deter-
mination method of Reddi (7), our procedure resulted
in a three-to-four-fold increase of sensitivity (fig. 6).
Both methods showed results which correlate very
well (r = 0.935).
1.0
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25 30
Fig. 5. Time-dependent linearity of the assay. The activity of a
serum sample was investigated each minute over a reac-
tion period of 30 min.
viation 9.3%) for those diluted with water. Because
of this significant difference (p < 0.001) dilution of
serum with a 150 mmol/1 NaCl solution is recorn-
mended. Thus the NaCl coticentration in the reaction
mixture is 50 mmol/1, which is also best for the
monovalent cation effect.
The stability of ribonuclease was studied on 10 serum
samples stored at room temperature (about 23 °C),
4°C, and -20°C (tab. 4).
Tab. 4. Stability of ribonuclease in serum under different
storage conditions. Catalytic activity measured in each
of 10 different serum samples within 3 hours of drawing
the blpod was considered to be 1.00. Data are given s
fraction of this starting catalytic activity (arithmetic
mean ± SD).
Storage
time
(d)
1
2
3
5
7
14
Fraction of starting catalytic
23 °C
1.01 -h 0.07
0.99 ± 0.08
0.95 ± 0.10
0.96 ±0.11
0.73 + 0.16
0.52 H- 0.21
4°C
1.05 + 0.04
1.00 ±0.07
1.05 + 0.05
1.04 ±0.09
activity
-20 °C
1.03 + 0.07
1.02 ±0.04
1.02 + 0.06
1.08 ±0.08
1.01 ±0.10
0.99 ± 0.08
Tab. 5. Precision data for the determination of catalytic activity
of ribonuclease.
n Catalytic activity (kU/1)
SD CV (%)
10
10
10
14
Within series
9.7
28.1
28.0
Between seriesb
26.5
0.31
0.62a
1.20a
2.09
3.19
2.20
4.28
7.88
* Determinated hv two different investigators.j~*widui.AJuaivu ujr v vs νιιΐλν>λ<b
 During a period of 42 days
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Fig. 6. Comparison of the catalytic activity of serum ribo-
nuclease äs determined by the present method (ordinate)
and by use of the method according to Reddi (7) (ab-
scissa). y = 3.39 H- 11.5; r = 0.935; n = 27.
Reference intervals in healthy adults
To determine preliminary reference ranges, the cata-
lytic activity of ribonuclease was assayed in the sera
of blood donors (n = 63; 32 females, 31 males) with
normal values of serum creatinine. The age structure
of women (ages 23 to 53 years; mean value: 37.1 ±
8.6 years) did not differ from that of men (ages 22
to 55 years; mean value: 34.1 + 8.5 years). Distribu-
tions of ribonuclease values, estimated by use of the
X2-test, did not show any significant deviations from
Gaussian distribution. No sex-related differences were
found (22.2 ± 5.1 kU/1 for women; 21.5 ± 5.2
kU/1 for men). Therefore, the preliminary reference
intervals listed in table 6 were established with the
combined data of males and females.
Discussion
Although the diagnostic evidence of ribonuclease in
various diseases has been discussed (1 — 12), detailed
Information is lacking because methodical problems
in the determination of this enzym? feave not yet been
resolved. Recently, many authors Äave attempted to
investigate this problem more systematically with re-
gard to the different methods used in activity meas-
urements (10, 21, 23).
Various methods have been employed for ribo-
nuclease determination: spectrophotometric methods
differing with their use of Substrates, for example
RNA from yeast (1^-3), transfer RNA from yeast
and Escherichia coli (23), and different polynucleot-
ides (15, 17, 24), methods using radiolabeled sub-
strates (25), and radioimmunoassäys (14). in routine
diagnostics, spectrophotometric methods are of
special interest. In comparison with naturally occur-
ring Substrates like RNA from yeast, the use of syn-
thetic Substrates offers advantages for the standafdiz-
ation of methods. Polycytidylic acid (7) has been
recommended for this purpose although the different
isoenzymes of serum ribonuclease are not equally able
to hydrolyse this Substrate (14, 15). In comparative
determinations of catalytic ribonuclease activity in
sera, Scott (23) found a good cörrelation between the
values of the catalytic activity of the so-called total
ribonuclease (determined with tRNA) and the cyti-
dine-specific ribonuclease. However, it is surprising
that in general the method elaborated for pancreatic
ribonuclease (16, 17) is also used to determine this
enzyme in serum (7, 24). Corbtshley et al. (10) became
aware of this problem by the high imprecision data
that they obtained with the original method accord-
ing to Reddi (7). By decreasing the Substrate concen-
tration Corbishley et al. (10) succeeded in improving
the analytical reliability of ribonuclease measure-
ment. Unfortunately, they did not systematically
study other analytical variables like buffer and pH,
cation effects, and the precipitation procedure. In
order to äs far äs possible eliminate the mentioned
effect of isoenzymes on the development of the
method the experiments were performed with a pool
of 30 serum samples obtained from healthy persons.
Tab. 6. Parametric (Gaussian) percentile calculations of catalytic concentrations of ribonuclease in 63 blood donors with normal
creatinine values. The 50th percentile is given with Standard deviation. Further details are given in thej:ext.
Percentiles
Ribonuclease (kU/1)
1
9.9
10
15.3
50
21.8 ± 5.1
90
28.3
97.5
30.2 ,'
99
33.7
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The Substrate concentration we recommend is com-
parable to the concentration proposed by Corbishley
et al. (26) but giving no further details. The data
show that this concentration is also acceptable for
serum enzyme determinations in patients with renal
dysfunction and for ribonuclease measurements in
urine.
For the determination of ribonuclease with polycyti-
dylic acid äs Substrate, buffers like potassium phos-
phate (21), potassium phosphate combined with so-
dium borate (7), and tris(hydroxymethyl) aminome-
thane (4) were used. As our experiments clearly illus-
trate, the pH Optimum of the catalytic activity of
ribonuclease depends on the buffer used. Whereas the
phosphate buffer in increased concentrations inhibits
ribonuclease, imidazole acts like an activator. Similar
buffer effects have been observed with transfer RNA
äs Substrate (23). Thus the observed pH behaviour
of ribonuclease is also a result of a specific buffer ion
effect. The expression "acid" and "alkaline" ribo-
nuclease corresponding to the pH optimum in various
buffers is not advisable and should be avoided (26).
Employing the ispelectric focusing method, three iso-
enzymes of ribonuclease in their basic, neutral, and
acid forms were detected in human serum (12).
Different procedures have been described for stop-
ping the catalytic activity of ribonuclease after the
incubation period chosen and for precipitating the
undegraded Substrate (17, 27). The reaction products
in the supernatant and consequently the measured
absorbance also depend on the precipitating reagent
used (e. g. perchloric acid alone or in combination
with lanthanum nitrate pr uranium salts) (17). The
precipitation technique using perchloric acid and lan-
thanum nitrate has been mostly recommended but
there has not yet been a systematic study of the
effects of these compounds. In general, 0.6 mol/1 of
perchloric acid is used äs a final concentration to
precipitate the unreacted Substrate (7, 26). Our results
prove that it is neeessary to reduce this concentration
to avoid any unspecific decomposition.
Compared with the traditional method for determin-
ing ribonuclease activity with polycytidylic acid ac^
cordihg to Reddi (7), our modified method is more
sensitive and has the following ädvantages:
1. The method is optimized with regard to all the
analytical variables which influence the reaction rate
of ribonuclease and with regard to the measurement
of products caused by this ribonuclease action.
2. Being a micromethod, it costs less. Reagents for
one test cost about 15 cents in comparison with about
one dollar for the method of Reddi (7).
3. By using complete buffer/substrate mixture and
avoiding further dilutions after stopping the reaction,
one person is able to make about 200 determinations
a day.
We were not able to perform comparative determina-
tions between our method and the recommended
method with tRNA äs Substrate (26). But Scott (23)
observed about five fold higher catalytic ribonuclease
activities determined with polycytidylic acid äs sub-
strate than with tRNA. As our modified method
resulted in a three to four fold increased sensitivity
in comparison wi#i the traditional method for deter-
mining ribonuclease activity with polycytidylic acid
according to Reddi (7), we assume that ten to twenty
fold higher values are obtained with our method
compared with the method using tRNA äs Substrate.
To characterize the method further, the catalytic con-
centration of ribonuclease activity was measured in
blood donors. It is generally accepted that ribo-
nuclease increases with age and is independent of sex
(24). The age influence was not investigated because
our subjects had relatively close ages. Therefore, our
reference intervals can only be considered preliminary
for adults. Our values, however, are higher than those
so far described with the Substrate polycytidylic acid
(24). Previpusly reported mean values for subjects in
the age ränge 20 to 50 years lie between 10 and 13
kU/1. With our optimized reaction conditions, we
found a mean value for 21.8 kU/1.
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